Clinicians and people have differing viewpoints on and expectations of telehealth and other types of digital treatment. Digital health know-how product leaders perform a crucial role in aligning these viewpoints and expectations so that they can aid supply what healthcare people want without the need of introducing to clinicians’ burdens.
Ever more, individuals have large anticipations of their health care encounters, which include these that come about virtually.
Virtual technological know-how can assist address issues in obtain and ease of care through, for illustration:
Telemedicine
Healthcare clinics in retail suppliers and pharmacies
Digital health and fitness apps
Remote monitoring products and wearables
Or subscription-based memberships
Consumers want treatment delivered the place, when, and how the desire it. In addition, they want superior interaction, digital engagement, and conversation with companies.
Which is improved from in advance of the pre-pandemic baseline. Then, individuals and sufferers ended up primarily contemplating – and employing – virtual care for prescriptions refill. In accordance to a survey of 7,000 individuals by the Advisory Board, willingness has completely shifted currently. For example, extra than 60{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} of individuals would now take into consideration going digital for ongoing treatment, pre-surgical appointments, and publish-surgical comply with-ups, or acquiring oncology benefits. And there’s much more.
Medical professionals are not so confident about digital treatment
When some physicians are nevertheless on the fence, businesses are all in. In the 2022 KFF Study of Employer Well being Added benefits, 90{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} of employers said telemedicine will be vital in offering obtain to care for behavioral, primary, and specialty care, and in remote options.
How can electronic overall health technological innovation help remodel care?
Digital health engineering companies and product leaders can engage in an crucial role in improving the healthcare knowledge and the wellness of people. For case in point, they can help decrease the disconnect amongst clients and providers.
A great digital care solution can also improve the romance amongst the patient and the supplier by aiding clinicians hone their “web-side” manner, the digital substitute to bedside manner. A further way is to emphasis on smart affected individual schooling with the proper content material and applications as an powerful alternate to help control queries questioned to clinicians.
Expectations and thoughts about virtual care and telehealth will most likely proceed to change. But for organizations and innovators in digital overall health technologies, the time to act on the prospect is now.
Uncover the vital position electronic overall health technologies corporations and leaders can participate in in aligning the expectations of clinicians, sufferers, and health and fitness plans, and how they can travel health care forward in our new whitepaper, Aligning Digital Treatment Delivery to Consumers’ Expectations.
ALL EYES ON THE FREE STATE OF FLORIDA — Florida Gov. Ron DeSantis has helped bring the once-fringe medical freedom movement onto the national stage, and lawmakers across the country are paying attention, POLITICO’s Megan Messerly, Arek Sarkissian and Krista report.
Building on his popular handling of Covid-19 in the state, DeSantis launched a “Prescribe Freedom” campaign last month that aims to permanently limit Covid-19 vaccination and mask requirements and give cover to doctors whose medical views depart from scientific consensus. It’s designed to protect “Floridians from the biomedical security state” — and if DeSantis declares his candidacy as expected, all Americans will start hearing more about it.
Many state lawmakers already like what they see. “Governor DeSantis has been leading the way,” Texas state Rep. Matt Schaefer told POLITICO. “A lot of people are looking to DeSantis to see what he’s doing at this point, and it gives cover to other governors, I think, to step out there.”
This year, state lawmakers have introduced more than 400 bills promoting a small-government vision for public health, according to the National Academy for State Health Policy. Some are Covid-specific, such as a bill in Indiana that would prohibit employers from requiring routine testing for the virus. Other proposals would make significant changes to the mandate-driven approach to public health.
Most aren’t expected to go anywhere. But their volume speaks to the backlash federal pandemic policies have engendered and how DeSantis’ proposals could be the inevitable result of so many Americans losing trust in local, state and federal health officials.
“Taking a different approach in public health requires a lot of guts,” Brian Miller, a non-resident fellow at the American Enterprise Institute, told POLITICO. “The public health community has historically not done a good job in integrating centrist, conservative and libertarian viewpoints.”
WELCOME TO WEDNESDAY PULSE.Nearly half of U.S. adults believe SARS-CoV-2 was leaked from a laboratory in Wuhan, China, dwarfing the quarter of Americans who believe it spilled over from animals to humans. Send your news and tips to [email protected] and [email protected].
TODAY ON OURPULSE CHECK PODCAST, hear more from host Megan Messerly and Krista Mahr about the medical freedom movement and how Ron DeSantis is bringing it into the mainstream.
FIRST IN PULSE — Sens. Maggie Hassan (D-N.H.) and Mike Bruan (R-Ind.) will reintroduce a bill today that aims to close a loophole pharmaceutical companies have used to block other firms from selling competing drugs, including lower-cost generics, PULSE has learned.
What the bill would do: The FDA often requires manufacturers to have a Risk Evaluation and Mitigation Strategy program for potentially dangerous drugs, which some companies patent to delay other, potentially cheaper versions coming on the market. The Increasing Prescription Drug Competition Act would allow the FDA to immediately approve drugs if a REMS patent is the only barrier to approval.
Its reintroduction follows a Monday New York Times report on Jazz Pharmaceuticals’ use of this tactic to block the release of a drug from a competitor.
“Our bipartisan bill would finally close this absurd loophole that big pharmaceutical companies, such as Jazz, can use to slow down the release of better, cheaper drugs in order to line their own pockets,” Sen. Hassan said in a statement to Pulse. “For too long, Big Pharma has artificially inflated drug prices at the expense of patients, but it doesn’t need to be this way. I will continue working across the aisle to take on Big Pharma and lower health care costs for all Americans.”
AND SPEAKING OF WUHAN … Congressional Republicans want to use new Covid-19 lab leak reports to lash out at Beijing and paint President Joe Biden’s administration as soft on China, but they can’t agree on how to do that, POLITICO’s Alice Miranda Ollstein and Gavin Bade report.
A spectrum of responses played out Tuesday across nearly a dozen hearings and legislation markups aimed at deterring what GOP lawmakers say is increasingly aggressive behavior from China that the Biden administration hasn’t effectively addressed.
Some hope a reported new assessment from the Energy Department, concluding that the so-called lab leak theory is the likely explanation for Covid’s origin, will give new life to legislation that stalled last year — including introducing bills to declassify intelligence about the pandemic, setting up a 9/11-style nonpartisan commission to study the virus’ beginnings and restricting data-sharing with Chinese scientists.
Others want the White House to hold classified briefings on what they knew about Covid-19’s origins, when they knew it and what led to the latest agency assessment. Still others hope to use the lab leak assessment as momentum for sanctions and investment restrictions on the world’s second-largest economy.
THE LAST LINE OF CARE— A CDC report released today shows that from 2018 to 2020, Black adults sought help in emergency departments for problems related to mental health at far higher rates than white or Hispanic adults. Their rates of emergency visits for specific disorders, such as anxiety disorder and substance use disorder, were also highest among Black adults.
At the same time, ED visits by Black patients “were less likely to result in admission or transfer to a hospital” than visits by white patients, the report said.
Hispanic adults had the lowest rates of ED visits for any mental health disorders.
The backdrop: One in 5 American adults were estimated to be living with a mental health disorder in 2020, and less than half of those individuals received any services for the condition.
Black and Hispanic individuals are less likely to receive mental health treatment than white Americans.
OUCH — During the Trump Administration, Don Rucker oversaw the beginning of the Trusted Exchange Framework and Common Agreement, a health data-sharing project known as TEFCA. Rucker had some choice words for the way the CDC handles health data — and how the agency wants to use TEFCA — in a recent interview with Ben Leonard over at Future Pulse.
“The CDC doesn’t get modern computing,” Rucker told Ben. “If you want to fight the next pandemic, where you actually have to monitor a population in real time, you can’t generate enough queries to do that. TEFCA doesn’t lend itself to population-based surveillance.
“CDC should totally shift its focus from trying to ingest little pieces of information to funding every gap in health information exchanges in the states,” he said.
Theo Merkel will join the Paragon Health Institute as director of its Private Health Reform Initiative and a senior research fellow. Merkel is a former special assistant to the president for economic policy at the National Economic Council in the White House and former legislative director for Sen. Pat Toomey (R-Pa.).
In STAT, a former deputy chief of staff for the Department of Health and Human Services calls on the FDA to rethink how new drugs for rare diseases are developed and remove needless obstacles that hinder clinical trials.
The Chinese doctor who claimed to have genetically engineered babies has staged a rocky return to science, The Associated Press reports.
As tensions rise with Washington, D.C., Beijing is trying to rewrite its response to the pandemic, The New York Times reports.
He sports a bushy white mustache and a bit of a gut. He dances to reggaeton in cities and towns across Mexico. He has 2 million followers on TikTok and at concerts is routinely passed into the arms of pop stars. His face even adorns a mountainside.
He is Dr. Simi, the cartoon mascot of Farmacias Similares, Mexico’s largest drugstore chain, with more than 8,500 locations across the country. His ubiquity speaks to the company’s round-the-clock marketing strategy but also something darker: the failure of the Mexican government to deliver on its promise of healthcare for all.
Medicines are often in short supply in public clinics, where it can take weeks to get an appointment with a primary care doctor.
At Farmacias Similares’ corporate headquarters, an employee sits at her desk adorned with Dr. Simi dolls and stickers.
(Luis Antonio Rojas / For The Times)
Farmacias Similares helps fill the gap with cheap generics and $2 doctor visits. The chain says its clinics next to each location provided 136 million appointments last year.
Many pharmacies feature an employee in a Dr. Simi padded bodysuit waving to passersby and engaging in antics such as challenging the cow mascot of Mexico’s Alpura milk brand to a dance-off.
Various Dr. Simis pose for a photo at an event in 2022 to celebrate the company reaching its target of 8,000 pharmacies.
(Farmacias Similares)
At the company’s headquarters in Mexico City, a mural shows Dr. Simi with a raised arm declaring: “To serve God and the people!”
Dozens of employees there answer calls to the “Simitel” hotline that provides free access to doctors, nutritionists and psychologists — and for those who press “1” to Dr. Simi himself.
Operators who have perfected the mascot’s cheerful nasal voice answer several hundred calls a day by reading a joke from a binder or simply offering a friendly ear. Alberto González, who has played Dr. Simi for nearly 17 years, cherishes callers such as 27-year-old Luis, who dialed in more than a decade ago to talk about his parents’ divorce and still phones every few weeks.
Alberto González, who takes on the role of Dr. Simi on the company’s hotline, waits for calls from people who want to chat with the mascot.
(Luis Antonio Rojas / For The Times)
The operators never break character.
“Hello, hello! How are you?” goes the script. “You’re talking to Dr. Simi. Who is calling me?”
::
In 1997, Mexico began requiring drugs to be labeled by their active ingredient rather than a name brand. The idea was to increase confidence in medications and open up the market to generic drugs.
The new rules were a business opportunity for Victor González Torres, whose family company had long manufactured drugs for the government health system.
That year, he founded Farmacias Similares. The name is a reference to generics, which were advertised with the slogan “The same, but cheaper.”
Promising “up to 75{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} in savings,” the company launched a marketing campaign that presented the chain as coming to the rescue of poor Mexicans and pushed back against transnational pharmaceutical companies that disparaged generics.
A mural depicting Victor González Torres, the founder of Farmacias Similares, at the company’s headquarters.
(Luis Antonio Rojas / For The Times)
González wanted a mascot with the right combination of goofiness and wisdom. After rejecting several ideas from an advertising company, his team found an artist who designed the winner: a simple black-and-white drawing of a doctor joyfully holding up his arms. The inspiration came from a famous movie character from the 1940s, Don Susanito Peñafiel y Somellera.
Dr. Simi first appeared in newspaper advertisements. He then took shape as an animated cartoon and a puppet on television, happily explaining why the public should trust generics.
An employee holds a sign advertising a sale outside the first Farmacias Similares pharmacy in Mexico City.
(Luis Antonio Rojas / For The Times)
Before long, Dr. Simis were dancing on the sidewalks. The company created a comic called “The adventures of Dr. Simi” and a band of “Simichicas,” well-known actresses and models who traveled with the founder and promoted new products such as the “Simicondom.” “SimiInsurance” offered medical treatment for a premium.
One of the chain’s key moves was to open clinics — which are operated by a sister company — alongside its pharmacies.
The cheap clinics made healthcare more accessible to the tens of millions of street vendors, taxi drivers and others working in the country’s informal sector. It was a population excluded from public health insurance systems — in apparent breach of the Mexican Constitution, which was modified in 1983 to make healthcare a universal right.
A doctor prepares an injection for Carmen Maldonado, a regular patient at his clinic next to a Farmacias Similares pharmacy.
(Luis Antonio Rojas / For The Times)
Like some political parties, the chain also handed out free rice and offered social assistance in poor neighborhoods.
Its populist strategy worked. By 2003, Farmacias Similares had roughly 1,000 locations and was looking abroad.
The government healthcare system expanded substantially the next year under a new program known as Seguro Popular that offered health insurance to workers in the informal economy. But that didn’t appear to stall the growth of Farmacias Similares. Catering to hourly workers who couldn’t afford to take time off to travel to public health centers, the chain placed its pharmacies on busy streets, often near bus stops, and grew rapidly by offering franchises.
By operating on a massive scale and manufacturing many of its own drugs, the company cut costs further and passed on the savings to customers.
“Victor González Torres and Farmacias Similares executed a tremendously effective strategy,” said Michael Chu, a Harvard business professor who has studied the chain.
González’s profile was growing too. Long encouraging people to call him Dr. Simi, he did not hide his desire for prestige, declaring once that he wanted to be remembered as a revolutionary like Che Guevara.
He butted heads with officials in the public health system after alleging corruption in its drug-purchasing practices and campaigned for president as a write-in candidate in the 2006 election.
“Poor people can have power in a country where there are so many,” he said in an interview at the time. “They can choose a president.”
The company has also waded through a fair share of controversy. González’s brother was the founder of Mexico’s Ecological Green Party, which in 2010 faced accusations of conflict of interest after sponsoring legislation to provide people with vouchers for medications in private pharmacies. The media dubbed it the “Simi law.”
The law failed to pass, but Farmacias Similares continue to grow amid the government’s faltering attempts to improve the public health system.
More than a quarter of the population lacked access to care in 2020, according to the government’s most recent estimate.
That same year, President Andrés Manuel López Obrador replaced Seguro Popular with a new program he promised would reduce corruption. But it has been beset by medicine shortages that experts attribute to bureaucracy and the COVID-19 pandemic. The government is currently transitioning to yet another program.
As a result, clinics next to private drugstores have been booming and are now thought to serve roughly a fifth of the population. Farmacias Similares opens nearly two new locations a day on average.
Carmen Maldonado, who owns a shop that sells artisanal honey and cheeses, recently dropped by Farmacias Similares’ first store — located in Mexico City’s Portales neighborhood — to buy cold medication and antibiotic injections, which a doctor administered at the clinic next door. A sign outside advertised birth control, oxygen and blood sugar readings, stitches and ear cleanings.
Maldonado could opt to use the public system, but the clinic is near her home and she’s been seeing this doctor for 20 years.
“He’s like the family doctor,” she said.
::
In November 2021, a 19-year-old high school student named Avril Christelle Vega Martinez was on her way to a concert in Mexico City when she stepped into a Farmacias Similares to pick up some hand sanitizer.
She had also been looking for a Dr. Simi doll, so she was happy to find the store had one left in stock. The dolls come in different guises — including boxer, mariachi and fireman — but the one she bought was the classic version: Dr. Simi in his lab coat.
A variety of Dr. Simi dolls fill the bookshelf of an employee at Farmacias Similares’ headquarters.
(Luis Antonio Rojas / For The Times)
Vega had taken the doll out of her backpack at the concert — Norwegian electro-pop singer Aurora Aksnes — when an idea popped into her head.
“I suddenly thought of the idea of maybe giving it as a present to Aurora,” she recalled. “Dr. Simi is a symbol of Mexican culture. We grew up seeing Dr. Simis dancing everywhere.”
And so she passed the doll up through the crowd until someone flung it onto the stage. Aurora picked up Dr. Simi and hugged him to her chest.
Captured on video, the incident went viral on social media, and it wasn’t long before Dr. Simi dolls were routinely being thrown onstage at concerts of pop stars including Dua Lipa and Rosalía.Joining in on the fun, a former chief justice of Mexico’s Supreme Court “ruled” on TikTok that doing so isn’t a crime.
The publicity was good news for Farmacias Similares. Dolls were selling so fast that the company boosted monthly production to 40,000 from 12,000. When one was left at a memorial for Queen Elizabeth II in Edinburgh last year, Mexican media outlets thought it newsworthy enough to cover.
The company carefully guards Dr. Simi’s image. The more than 1,000 staffers who wear Dr. Simi bodysuits are forbidden to speak to the public while in costume in order to preserve the character’s identity. One benefit of the job: lessons in dancing salsa, cumbia and the Simi pasito.
A communications team works a night shift to produce seven television shows a week, bringing in specialists to discuss anxiety and stress, as well as staffers from different areas to explain their jobs. Employees keep a close eye on social media, tracking down for an interview members of the public who have helped Dr. Simi go viral.
The company also promotes its brand through what VictorGonzález Herrera, the son of the founder, called “conscious capitalism” — funding natural disaster relief, tree planting and food assistance for the hungry.
In December, the company raffled 25 cars to customers to mark its 25th anniversary. Before the winners collected their new car keys, pharmacy employees launched into the corporate anthem:
We have the courage Dr. Simi has the heart What we offer We do with love
With pharmacies in all of Mexico’s 32 states and more than 400 in Chile, the company aims to reach its target of 10,000 pharmacies in the next five years and ultimately become the largest chain in the world.
“Simi has simply become necessary,” said Victor González Herrera, who recently took over as head of an umbrella group that includes the pharmacies and the clinics.
Health experts have warned that while the pharmacy clinics can treat immediate illness, they are not ideal for chronic conditions.
“Can it be a business that does good? Without a doubt,” said Dr. Andrés Castañeda, who coordinates health issues for Nosotrxs, a Mexican organization that promotes citizen participation in public policies. “But the health system can’t leave things 100{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} in the hands of clinics adjacent to pharmacies.”
One problem is that the care may not be consistent, because the doctors tend to come and go.
But Cori Hayden, an anthropologist at UC Berkeley who recently published a book on Farmacias Similares called “The Spectacular Generic,” said that many people have resigned themselves to “something is better than nothing” when the state fails to provide healthcare.
“It’s a force. It’s wild,” she said of the chain. “It’s totally wild.”
But its true power remains something of a mystery, because Farmacias Similares keeps its sales figures private.
“It’s a gray area,” said Jorge Perichart, director of the National Assn. of Sales Executives of the Pharmaceutical Industry. “We don’t know what we’re competing against.”
::
A family peers out from a home in the “Simi Neighborhood.”
(Luis Antonio Rojas / For The Times)
About 30 miles north of the center of Mexico City, in a mountainside community in the municipality of Ecatepec, the homes have bare concrete floors and tin roofs. Access to running water is a luxury.
For Farmacias Similares, the Lomas de San Carlos neighborhood was not just a symbol of neglect: It was a canvas.
Last year, the company sent in representatives offering residents food assistance and free house painting. Then painters got to work on 305 houses.
The result was an advertisement for Farmacias Similares visible from the nearby highway.
White houses make up a man’s bushy mustache, pink houses his tongue, and black-striped houses the three wiry hairs on each side of his head.
It was, of course, Dr. Simi.
Hundreds of houses in the municipality of Ecatepec have been painted to form a mega-mural of Dr. Simi.
(Luis Antonio Rojas / For The Times)
The company — which also remodeled the community center, built a vegetable garden and opened two new pharmacies nearby — dubbed Lomas de San Carlos “Simi Neighborhood.” Reporters rushed to cover the story.
“No one has ever paid this much attention to us,” said Hortencia Olivares Ramos, whose home was painted blue — the background of the mural.
At the mountain’s peak, Eva Ojeda López lives with her husband and four children in a house painted to match the hairs on Dr. Simi’s balding head.
The stay-at-home mother buys her hypertension pills at Farmacias Similares when the public pharmacies run out and frequents the company’s clinics for basic ailments such as colds.
Ojeda swore that the arugula from the new community garden lowered her cholesterol levels. One of her daughters read the book that Farmacias Similares gifted the family: the founder’s autobiography, “My Life Is a Struggle.”
Another daughter Johana, 18, joked about how some of her neighbors lived by Simi’s tongue or his eyes.
“We consider ourselves a part of Dr. Simi,” she said.
Dr. Gregor obtained his Doctorate in Physical Therapy in 2008 and his Geriatrics Specialization from the American Board of Actual physical Therapy Specialties in 2014.
Neil has provided Geriatrics centered treatment in property health and fitness, competent nursing and outpatient configurations. Dr. Gregor is a Director of the Northern California VA Well being Treatment System’s (VANCHCS) Work out and Wellness Program, GEROFIT. He is also Director and a Mentor for the VANCHCS Geriatric Actual physical Treatment Residency Method. As a credentialled Clinical Teacher, Neil has taught Actual physical Therapy college students for in excess of 10 many years.
Dr. Gregor has graciously donated his time to his career. He has served as a general public reviewer for medical apply recommendations for rehabilitation next hip fracture and as a state advocate for the Academy of Geriatrics beneath the American Actual physical Therapy Affiliation. Neil has a deep seeded passion for Geriatrics centered instruction, rural wellness care and preventative drugs companies. Previously mentioned all, what Dr. Gregor loves most in his vocation, is offering individual-centered care, acquiring meaningful connections with individuals he serves, and the countless lifestyle classes figured out from them.
Dr. Angela Brigham, PT, DPT
Web page Coordinator of Clinical Training
Dr. Angela Brigham received her Doctorate in Actual physical Remedy degree from Samuel Merritt University in 2009.
After graduating, she started off her vocation in the private sector at a experienced nursing facility. In 2011, Dr. Brigham began her journey with the VA, taking a place in the Heart for Rehabilitation and Prolonged Care in Martinez, CA. She took above the role of Site Coordinator of Clinical Education and learning (SCCE) for the Northern. California Well being Care System in 2014. Due to the fact having in excess of the position as SCCE, she has put dozens of learners at various web-sites in the course of Northern California. Angela is a accredited clinical teacher and individually can take 1-2 learners every year. Angela is currently serving her 2nd two-year phrase as a member of the Countrywide Clinical Education and learning Strategic Workgroup, a group aimed to guide Actual physical Therapy medical educators in VAs throughout the nation. Angela serves as the coordinator for the Geriatric Residency Application and will also serve as a mentor for the resident.
Dr. James A. Patrizi PT, DPT, CWS, FACCWS
APTA certified medical teacher
Patrizi attained his Actual physical Treatment diploma from Northwestern College and his transitional Doctorate in Actual physical Therapy from the University of the Incarnate Phrase.
He earned his Wound Professional Certification and Diplomate designation from the American Board of Wound Management in 1999 and was named a Fellow of the Faculty of Accredited Wound Professionals in 2005. He has been adjunct college for two DPT applications for 15 many years, training the Integumentary curriculum. Patrizi’s apply concentration has been limb salvage for people with vascular condition and edema management. On top of that, he has been a voting member of the VISN 21 Interprofessional Subcommittee, the Wound Care Process Pressure, and the Merchandise Evaluate Committee. He routinely conducts team training and just one-on-one mentoring for DPT college students and RN, LVN, PA, NP pupils, and MD/DO people rotating by the facility. Other things to do involve ongoing evaluation/implementation of rising state-of-the-art products and solutions linked to tissue therapeutic, wound cleansing/irrigation, and vascular system variety for rental/acquire for the inpatient and outpatient populations. Patrizi is an APTA qualified Clinical Teacher.
Dr. David Crivello, PT, DPT, OCS, CSCS
Physical exercise and wellness plan, Gerofit co-director
Crivello received his Doctorate of Physical Therapy Degree from the University of the Pacific in 2012.
He reached his Orthopedic Specialization from the American Board of Bodily Remedy Experts in 2019. Crivello’s clinical encounters lie principally in outpatient orthopedics but consist of Residence Health and fitness Bodily Treatment and Acute Care Physical Treatment. Crivello joined VA Northern California in 2015. In preparing for his Orthopedic Specialization, Crivello attended a yearlong Musculoskeletal Residency at Baylor College in 2018. He at this time serves as the Co-Director of the VA Northern California Gerofit System. He is also a board member of the National Pilot Application for Joint Wellbeing Administration in conjunction with the Memphis VA. Dr. Crivello also is a accredited Dry Needling practitioner. Crivello serves as a facility member and mentors for the VA Northern California Geriatric Residency Program.
Dr. Maggie Limmer, PT, DPT, OCS
Instructor
Limmer earned her Doctorate in Bodily Therapy in 2018 from the University of Evansville.
She then entered the Utah Orthopaedic Bodily Treatment Residency, from which she graduated in 2019. Her passion for the VA began right here, as she put in most of her clinic time at the George E Wahlen VAMC in Salt Lake City. She worked at the College of Utah Health and fitness system’s Utah Orthopaedic Centre. The time break up between these two facilities allowed Limmer to attain knowledge in numerous orthopedic situations, from managing geriatric sufferers with chronic discomfort to NCAA Division I athletes. Limmer then took her profession to Northern California, in which she acknowledged a job in outpatient orthopedics at Kaiser Permanente. She gained her Orthopaedic Specialization from the American Board of Actual physical Treatment Specialties in 2020. At Kaiser, she was element of a pilot application furnishing telehealth physical remedy providers, which proved handy as the COVID pandemic hit shortly right after. The change in clinical apply owing to pandemic safety measures permitted her to use her telehealth expertise. Just after two a long time at Kaiser, Limmer knew it was time to return to the VA method. She started out at Mather VAMC in August 2021, pivoting roles to function in acute care. She instantly became a part of the Acute Treatment for Elders (ACE) Staff, focusing on optimizing clinic outcomes for the senior populace. She also functions as a liaison for the Emergency Division and sufferers with orthopedic problems who land in acute treatment. Her eventual objective is to meld her orthopedic track record with her acute treatment expertise and develop into a musculoskeletal screener operating mostly in the Unexpected emergency Department.
Dr. Carolyn Patten PhD, PT, FAPTA
Teacher
Dr. Patten is a neuroscientist and bodily therapist who specializes in evaluating and treating motor dysfunction associated with growing old and adult neuropathologies, such as stroke.
She directs the UC Davis Biomechanics, Rehabilitation, and Integrative Neuroscience (Brain) Lab is a Co-Director of the UC Davis Middle for Neuroengineering and Medicine. In addition to her key college role at UC Davis University of Medication, Dr. Patten is a senior investigator with the VA Northern California Wellness Care Process. She holds Investigation Vocation Scientist standing.
Exploration Emphasis
Dr. Patten’s investigation focuses on knowing the neural foundation of human movement, investigating human motor manage, and learning from a standpoint of neuromechanics. Her laboratory has made approaches sensitive to motor impairment utilizing concurrent behavioral and neurophysiological procedures. The lab’s recent work emphasizes identifying biomarkers to predict motor recovery pursuing stroke and the essential components contributing to rehabilitation efficacy. To realize these goals, the Mind lab researches the neural mechanisms and biomechanical effects of CNS pathologies causing motor dysfunction, including novel strategies to induce neuroplasticity and motor restoration and unique versions in the program of motor restoration and responses to therapeutic interventions. Healthier Getting older in a Digital Environment – a UC Davis Large Notion, the Countrywide Science Foundation, the Office of Veterans Affairs (Rehabilitation R&D), and the College of California CITRIS support Dr. Patten’s study (Heart for IT Exploration in the Curiosity of Modern society). She has continuously held federal, peer-reviewed challenge funding as Principal Investigator since getting her first Vocation Advancement Award from VA Rehabilitation R&D in 1998.
Dr. Kate Schopmeyer, PT, DPT, CSCS, CPE
Instructor
Dr. Schopmeyer is a clinician, educator, and application coordinator specializing in interdisciplinary soreness rehabilitation.
She is actively driving apply adjustments for soreness treatment by means of countrywide and regional committees and workgroups, both equally in just the VHA and the non-VA wellbeing care local community. Her main objectives in medical perform are to foster active patient engagement by instruction, teach behaviors that promote self-management, and educate folks how to re-engage in life although dwelling with persistent suffering. She thinks ache care is a “team sport,” that expertise is ability, and that motion is the finest drugs.
Pune, March 01, 2023 (GLOBE NEWSWIRE) — According to Market.us, the global medical devices market accounted for USD 492 billion in 2022 and is projected to reach USD 656 billion by 2032, exhibiting a CAGR of 3.0{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} in the forecast period (2023-2032).
Medical devices are used to diagnose and treat diseases or injuries. These devices can be used to treat illnesses or improve patients’ quality of life. FDA (Food and Drug Administration) classifies medical devices into three classes: Class I, Class II, and Class III. Because they have the most regulatory controls, Class I and II require special labeling. These are the ones that sustain or support human life. These include an implant endosseous and an external defibrillator. Medical device establishments are those that manufacture medical devices. These devices include in-vitro diagnosis and diagnostic imaging devices.
By product, the In-Vitro Diagnostics segment (IVD) is expected to have the highest CAGR during the forecast period due to the increasing use of real-time diagnostic testing for diagnosing infectious and chronic diseases.
By end-user, the hospitals & clinics segment dominated the market in 2022 because of the rising healthcare spending, better healthcare infrastructure, and an attractive reimbursement policy.
In 2022, North America dominated the market with the highest revenue share of 43{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} due to the high treatment rates, supportive government initiatives for early diagnosis of diseases, and the increasing adoption of technologically advanced devices.
Asia-Pacific is expected to grow at the highest CAGR between 2023-2032 due to the increasing patient population suffering from chronic diseases and improving healthcare infrastructure.
Complex surgeries and growing numbers are driving this market. In addition, the market for medical devices is expected to grow due to technological advancements in medical technology, brain monitoring devices, and government initiatives.
Factors affecting the growth of the medical devices industry?
Several factors can affect the growth of the medical devices industry. Some of these factors include:
Technological Advancements: Advanced technologies like artificial intelligence (AI) and wearable medical equipment are becoming increasingly prevalent in the medical devices market nowadays. This is propelling the market growth positively.
Rising chronic diseases: The increasing cases of chronic diseases like cancer, diabetes, etc., will raise the patient population. A sedentary lifestyle is a major reason behind this. This is boosting the market’s expansion.
Increasing healthcare expenditure: The increasing per capita healthcare expenditure in developing and developed countries means more opportunities for medical devices, which is positively affecting market growth.
Growing awareness about diseases: The growing awareness about infectious diseases and chronic conditions means that individuals are taking necessary treatments readily. This is abetting the market growth positively.
Remote diagnosis, treatment, and monitoring of patients are possible now because of technologies like remote patient monitoring devices, artificial Intelligence (AI), wearable devices, and electronic health records. Patients can be monitored at their homes and hospitals via contactless technology. This is crucial in controlling COVID-19. Both patients and doctors can have an EHR for their patients. This means they don’t need to deal with traditional paperwork that must be sent through multiple people involved in the treatment. Patients and doctors can view the data on their own devices as well as those of other doctors.
Medical device manufacturers are seeking ways to reuse production lines to produce high-demand supplies to fight against the coronavirus. These products include hand soaps, ventilators, personal protective equipment (PPE), face masks, and other medical supplies. AirCo, a liquor producer, has shifted its focus to hand sanitizers. INKSmith Canada also produces face shields. It was a startup that made technology tools and designs more accessible for children.
Due to rising rates of chronic medical conditions and the treatment of those suffering from them, the healthcare system across different countries is facing immense pressure. This has led to a significant rise in the cost of treating these conditions. Hospital inpatient costs are significantly higher than the hospital charges for those treated at home. Additionally, longer hospital stays can result in a higher economic burden. A recent randomized study comparing hospital patients with those in home care showed that home care management costs decreased by 19{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}. There has been an increase in the preference for home healthcare services due to increasing economic burdens and a growing elderly population. Home healthcare services are becoming more popular in developed countries due to the increasing efforts of key players and healthcare agencies to develop and launch simple-to-use medical devices, such as portable and wearable devices for chronic illnesses. Shimmer Research, a world leader in wearable technology applications, introduced Verisense Pulse+ in March 2021. This sensor is designed for Verisense platforms and provides photoplethysmographs and galvanic skin reactions. This device measures the heart rate and oxygen saturation of clinical trial patients and their activity levels and sleep levels.
Market Growth
Living a lifestyle that leads to physical inactivity can increase the risk of developing heart disease. This will likely increase the demand for medical devices as more heart surgeries are performed to clear blocked arteries. This will help to boost the market growth. This market is expanding because companies focus on creating advanced products and using different business strategies, such as acquisitions or partnerships, to maintain their market position.
Regional Analysis
Regional analysis shows that North America is expected to continue to be the largest market in medical devices. This market dominance is due to the rising prevalence of chronic disease, high healthcare spending, and key players’ presence. Canada’s growing elderly population will likely boost market growth during the forecast period. According to United Nations Population Fund statistics for 2022, Canada has a large population aged between 15 and 64. This group makes up approximately 65{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} of Canada’s total population. According to the same source, 19{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} of Canadians are expected to reach 65 by 2022. Geriatrics are more susceptible to developing chronic conditions such as respiratory disease, cardiopulmonary disease, and orthopedic disorders. This trend over the forecast period is anticipated drive market growth. A rising number of chronic conditions such as stroke, heart disease, and cardiovascular disease has increased cardiopulmonary bypass procedures; therefore, medical devices have seen a significant increase in demand. According to American Heart Association, the United States is predicted to have a 6.8{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} heart disease prevalence by 2021, 1.8{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} higher than the overall population. This will help to increase demand for medical devices that improves diagnosis and treatment. This will likely boost the market’s growth over the forecast period.
Competitive Landscape
The global medical devices market is fragmented because of the presence of many market players on both a regional and global level. With its extensive product range and international reputation, Medtronic holds the largest market share. Most industry players invest heavily in Research and Development (R&D), which is used to develop new products and improve existing product lines. They also invest a lot in growing their global distributor networks, allowing businesses to diversify product offerings.
Have Queries? Speak to an expert, or To Download/Request a Sample, Click here.
Sedentary lifestyles and other factors increase chronic diseases like diabetes, cancer, and other infections. Through various awareness programs, healthcare agencies worldwide are trying to improve the speed of diagnosis and treatment. Due to the increasing prevalence of these conditions, the number of people who need diagnostic tests and procedures is on the rise. For example, the International Diabetes Federation stated that 537 million people were diagnosed with diabetes in 2021. IDF states this number will rise to 643 million in 2030 and 783 million by 2045.
According to the American Cancer Society, the number of new cancer cases in 2021 was 1.9 million. In addition, there is a rising demand for orthotic or ophthalmic procedures due to increasing numbers of joint fractures and poor vision in the elderly. Osteoarthritis Alliance 2021 data shows that the incidence of knee osteoarthritis is highest in those between 45 and 65 years old. About 45{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} of osteoarthritis patients are 65 years old or older. Along with these factors, higher per capita healthcare spending in developing and emerging countries and better reimbursement policies drive an increasing number of patients seeking treatment and diagnosis. This is driving demand for medical devices.
Due to rising rates of chronic medical conditions and the treatment of those suffering from them, the healthcare system across different countries is facing immense pressure. This has led to a significant rise in the cost of treating these conditions. Hospital inpatient costs are significantly higher than the hospital charges for those treated at home. Additionally, longer hospital stays can result in a higher economic burden Shimmer Research, a world leader in wearable technology applications, introduced Verisense Pulse+ in March 2021. This sensor is designed for Verisense platforms and provides photoplethysmographs and galvanic skin reactions. It also has an inertial measurement unit. This device measures the heart rate and oxygen saturation of clinical trial patients. It can also measure their activity levels and sleep levels.
Market Restraints
Most likely, new products and services will be more expensive due to regulatory changes. Data protection is affected by these regulatory changes. These regulatory changes can also affect equipment approval procedures. The US Food and Drug Administration (FDA) has requested additional clinical information. This information is needed to support safety claims and efficacy claims regarding medical devices such as endoscopies. Due to the potential loss of revenue due to delayed product releases and the higher costs associated with the stringent approval process, investments in product development have been under pressure. This can have a negative effect on the growth of medical device and equipment markets.
Market Opportunities
The largest medical device market segmented by type is In-vitro Diagnostics. Hospitals and clinics will benefit the most from the segmented market for medical devices by the end user. With US$ 55,700 million, the USA is anticipated to be the world’s largest medical device market. According to the Business Research Company, medical device companies should concentrate on disposable medical products, contactless medical devices, portable medical devices, and wearable medical gadgets.
A recent randomized study comparing hospital patients with those in home care showed that home care management costs decreased by 19{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}. There has been an increase in the preference for home healthcare services due to increasing economic burdens and a growing elderly population. In addition, home healthcare services are becoming more popular in developed countries due to the increasing efforts of key players and healthcare agencies to develop and launch simple-to-use medical devices, such as portable and wearable devices for chronic illnesses. These factors are creating ample amount of opportunities for the market.
In-Vitro Diagnostics (IVD) is expected to experience a higher CAGR. This is due to the increasing usage of real-time diagnostic tests to accurately diagnose chronic or infectious diseases such as diabetes, cancer, HIV/AIDS, etc. In addition, the increased demand for medical devices, such as gloves and masks, surgical lights, and fetal monitors, led to the other segments holding a dominant position in 2022. The wound management segment is expected to grow significantly due to the increased investment made by medical device companies into new wound devices and bioactive therapies. Minimally Invasive Surgery is predicted to grow because of technological advancements in surgical robots and increased use by healthcare providers. Due to the increasing number of patients suffering from different cardiac and orthopedic conditions, orthopedic and cardiovascular devices will likely continue growing rapidly. Market growth for medical devices is anticipated to be driven by the increasing incidence of diabetes and retinal disorders in the population.
End-User Insight
This segment’s notable growth can be attributed primarily to rising healthcare spending, improved healthcare infrastructure, and a favorable reimbursement policy. According to the WHO report on healthcare infrastructure, most developing countries have less than 1 million hospital beds. These countries invest heavily in healthcare infrastructure development. As a result, healthcare infrastructure spending is expected to increase over the forecast period.
FDA granted Abbott’s recall of its imaging catheter a Class 1 label in May 2022 because of vascular injury risks.
In January 2022, The US gave FDA approval to Mediatric’s Intellis rechargeable neurostimulator and Vanta recharge-free neurostimulator used for treating chronic pain caused by diabetic peripheral neuropathy.
Siemens Healthineers AG launched NAEOTOM Alpha in November 2021, which is the world’s first CT scanner that uses photon-counting technology cleared for clinical use in Europe and the US.
In August 2021, Johnson & Johnson introduced VELYS digital surgery. The robot-assisted option for total knee arthroplasty in the United States is now available.
Browse More Related Reports:
About Us:
Market.US (Powered by Prudour Pvt Ltd) specializes in in-depth market research and analysis and has been proving its mettle as a consulting and customized market research company, apart from being a much sought-after syndicated market research report-providing firm. Market.US provides customization to suit any specific or unique requirement and tailor-makes reports as per request. We go beyond boundaries to take analytics, analysis, study, and outlook to newer heights and broader horizons.
Underneath the Consolidated Appropriations Act, 2021 (CAA), group wellness options and wellness insurance coverage issuers are needed to yearly attest that they are in compliance with the CAA’s gag clause prohibition. On a substantial stage, the CAA’s gag clause prohibition rule basically prohibits options and issuers from coming into into agreements with suppliers, TPAs, or other service vendors that would restrict (i) provider-distinct price tag or quality information and facts sharing with prepare associates or (ii) claims knowledge (like specific promises pricing) sharing with prepare sponsors (and their services suppliers).
For each direction launched on February 23, 2023 by the Departments of Labor, Wellbeing and Human Services, and the Treasury (collectively, the “Departments”), the Gag Clause Prohibition Compliance Attestation (GCPCA) can now be submitted in this article. The very first GCPCA is due by December 31, 2023, covering the time period commencing December 27, 2020 (or the helpful date of the relevant team wellbeing prepare or wellness insurance plan coverage, if afterwards) by the date of attestation subsequent GCPCAs are thanks by December 31 of just about every 12 months and go over the interval considering that the very last GCPCA was submitted.
The recently unveiled steerage on the GCPCA, together with Commonly Asked Concerns, submission directions, a submission consumer guide and the reporting template, is available here. To assessment all of the important CAA requirements, you can obtain our checklist for approach sponsors here and our checklist for strategy company providers here.
As with other CAA specifications, a self-insured program can enter into an agreement to have their TPA, PBM or a further third occasion post the GCPCA on their behalf, but the lawful accountability to post a well timed attestation stays with the program. Similarly, absolutely-insured team health and fitness strategies may well offload the duty for submission of the GCPCA to the wellbeing insurance plan issuer, if carried out in composing. An issuer that each features group wellness coverage and acts as a TPA for self-insured group wellness plans can post a solitary GCPCA on behalf of itself, its absolutely-insured team health prepare policyholders, and its self-insured group well being approach purchasers. Even so, to avoid duplication, the Departments recommend that issuers acting as TPAs first coordinate with each individual strategy to ensure that the group overall health strategy does not intend to attest on its possess behalf for some or all of its provider agreements. There are distinct guidance relevant if an entity is publishing the GCPCA on behalf of multiple ideas.
Entities not essential to attest are issuers of only excepted rewards options or small-time period constrained-length insurance policies, Medicare and Medicaid strategies, CHIP, TRICARE, Indian Well being Assistance System, and Basic Wellness Software Programs. The Departments will not enforce the requirement to post a GCPCA against ideas that consist solely of health and fitness reimbursement preparations (HRAs), or other account-based group wellness ideas.
Almost talking, the significant lifting connected with submission of the GCPCA is likely to tumble on issuers and TPAs. Plans and issuers must overview their services agreements to decide how the GCPCA is included and to assure that every little thing is on keep track of for a submission to be manufactured by December 31, 2023.
If you have issues about compliance with the previously mentioned necessities, or are seeking for realistic pointers on how to include these new obligations into your existing business design, Foley & Lardner LLP can assistance.
